Profiling of pyrrolizidine alkaloids using a retronecine-based untargeted metabolomics approach coupled to the quantitation of the retronecine-core in medicinal plants using UHPLC-QTOF.


Journal

Journal of pharmaceutical and biomedical analysis
ISSN: 1873-264X
Titre abrégé: J Pharm Biomed Anal
Pays: England
ID NLM: 8309336

Informations de publication

Date de publication:
05 Feb 2023
Historique:
received: 23 09 2022
revised: 07 11 2022
accepted: 16 11 2022
pubmed: 3 12 2022
medline: 7 1 2023
entrez: 2 12 2022
Statut: ppublish

Résumé

Pyrrolizidine alkaloids (PA) are secondary metabolites of high toxicological relevance. Several PA quantitative methodologies were developed based on a limited number of certified standards, including time consuming solid phase extraction (SPE) purification steps. Herein, we shed light on the variability of PA in herbal extracts and propose a quantification methodology based on ultra-high-performance liquid chromatography high-resolution mass spectrometry (UHPLC-HRMS) for the evaluation of the total PA content as retronecine-equivalents (RE) directly from crude matrices. Particularly in the focus of the investigation were Alkanna spp. (Boraginaceae), which possess a wide range of pharmaceutical properties. In addition, a comparative PA screening of crude and SPE enriched extracts was performed and PA-containing plants from Fabaceae and Compositae families were included to demonstrate universal applicability. In total, 105 PA were identified using HRMS

Identifiants

pubmed: 36459765
pii: S0731-7085(22)00592-1
doi: 10.1016/j.jpba.2022.115171
pii:
doi:

Substances chimiques

retronecine 2P5723M6II
Pyrrolizidine Alkaloids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115171

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Evangelia Tsiokanos (E)

Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, 15771 Athens, Greece. Electronic address: evatsiokanos@pharm.uoa.gr.

Nikolaos Tsafantakis (N)

Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, 15771 Athens, Greece. Electronic address: ntsafantakis@pharm.uoa.gr.

Hélène Obé (H)

Pierre Fabre Research Institute, Green Mission Department, Herbal Products Laboratory, 3, Avenue Hubert Curien, BP 13562, 31035 Toulouse, France. Electronic address: helene.vercauteren@pierre-fabre.com.

Till Beuerle (T)

Department of Pharmaceutical Biology, Technical University of Braunschweig, Mendelssohnstr. 1, 38106 Braunschweig, Germany. Electronic address: t.beuerle@tu-braunschweig.de.

Mathieu Leti (M)

Pierre Fabre Research Institute, Green Mission Department, Herbal Products Laboratory, 3, Avenue Hubert Curien, BP 13562, 31035 Toulouse, France. Electronic address: mathieu.leti@pierre-fabre.com.

Nikolas Fokialakis (N)

Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, 15771 Athens, Greece. Electronic address: fokialakis@pharm.uoa.gr.

Antonio Grondin (A)

Pierre Fabre Research Institute, Green Mission Department, Herbal Products Laboratory, 3, Avenue Hubert Curien, BP 13562, 31035 Toulouse, France. Electronic address: antonio.grondin@pierre-fabre.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH